Showing results (501-510 of 631) with videos related to

Sort By:
Pageof 64
Investigative Ophthalmology & Visual Science|August 27, 2005
Suppression and regression of choroidal neovascularization by polyamine analoguesRaquel Lima e Silva, Yoshitsugu Saishin, Yumiko Saishin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2025
Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and CPaul R Sargunas, Emily Ariail, Raquel Lima E Silva, et al.
Rheumatology (Oxford, England)|October 5, 2017
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related diseaseAlvise Berti, Emanuel Della-Torre, Francesca Gallivanone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2007
The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularizationRaquel Lima e Silva, Jikui Shen, Sean F Hackett, et al.
Arthritis Care & Research|December 19, 2023
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic SclerosisGiulia Bandini, Alessia Alunno, Filipe O Pinheiro, et al.
European Journal of Internal Medicine|September 3, 2025
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin (hf-SCIg) for inflammatory myositis: a multicenter retrospective real-world observational studyAdalgisa Palermo, Edoardo Biancalana, Alessandra Bettiol, et al.
Scandinavian Journal of Rheumatology|September 24, 2015
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patientsC Campochiaro, G A Ramirez, E P Bozzolo, et al.
Rheumatology (Oxford, England)|November 22, 2022
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysisCorrado Campochiaro, Anna-Maria Hoffmann-Vold, Jerome Avouac, et al.
Microorganisms|October 29, 2025
Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of MyocarditisGiovanni Benanti, Marta Secci, Andrea Villatore, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 18, 2023
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilationAndrea Mastrangelo, Roberta Monardo, Laura Galli, et al.
Pageof 64